Aquestive Therapeutics【AQST】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

3.74

買値

3.59

売値

3.74

出来高

810,495

3.515 日の範囲 3.68

1.95 52 週間の範囲 6.23

時価総額

341.006M

前日終値

3.65

始値

3.65

時刻

200

3.74

(formt)

最終取引時間

07:39:21

財務取引量

US$ 2,898,409

VWAP

3.5761

平均取引量 (3 か月)

1,515,231

発行済株式数

91,178,193

配当利回り

PER

-41.60

1 株当たり利益 (EPS)

-0.09

歳入

50.58M

純利益

-7.87M

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the t... Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.aquestive.com

本社

Wilmington, Delaware, USA

設立

Aquestive Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker AQST. The last closing price for Aquestive Therapeutics was US$3.65. Over the last year, Aquestive Therapeutics shares have traded in a share price range of US$ 1.95 to US$ 6.23.

Aquestive Therapeutics currently has 91,178,193 shares in issue. The market capitalisation of Aquestive Therapeutics is US$332.80 million. Aquestive Therapeutics has a price to earnings ratio (PE ratio) of -41.60.

Form 8-K - Current report

Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five

WARREN, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful...

Form 8-K - Current report

Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm™ (epinephrine) Sublingual Film

Reaffirms New Drug Application (NDA) first quarter 2025 submission guidanceConfirms no additional adult clinical trials are necessary prior to NDA submission Commenced pediatric trial in the U.S...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.12	3.31491712707	3.62	3.915	3.38	1981508	3.6342946	CS
4	-0.89	-19.222462203	4.63	5.285	3.38	1697326	4.11741354	CS
12	-1.02	-21.4285714286	4.76	5.8	3.38	1515231	4.69119374	CS
26	1.18	46.09375	2.56	5.8	2.24	1412611	4.23669008	CS
52	1.74	87	2	6.23	1.95	1667355	4.0119816	CS
156	-0.35	-8.55745721271	4.09	6.23	0.618	878697	3.1122431	CS
260	-1.75	-31.8761384335	5.49	9.465	0.618	841977	3.91288188	CS

AQST - Frequently Asked Questions (FAQ)

What is the current Aquestive Therapeutics share price?

The current share price of Aquestive Therapeutics is US$ 3.74

How many Aquestive Therapeutics shares are in issue?

Aquestive Therapeutics has 91,178,193 shares in issue

What is the market cap of Aquestive Therapeutics?

The market capitalisation of Aquestive Therapeutics is USD 332.8M

What is the 1 year trading range for Aquestive Therapeutics share price?

Aquestive Therapeutics has traded in the range of US$ 1.95 to US$ 6.23 during the past year

What is the PE ratio of Aquestive Therapeutics?

The price to earnings ratio of Aquestive Therapeutics is -41.6

What is the cash to sales ratio of Aquestive Therapeutics?

The cash to sales ratio of Aquestive Therapeutics is 6.47

What is the reporting currency for Aquestive Therapeutics?

Aquestive Therapeutics reports financial results in USD

What is the latest annual turnover for Aquestive Therapeutics?

The latest annual turnover of Aquestive Therapeutics is USD 50.58M

What is the latest annual profit for Aquestive Therapeutics?

The latest annual profit of Aquestive Therapeutics is USD -7.87M

What is the registered address of Aquestive Therapeutics?

The registered address for Aquestive Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Aquestive Therapeutics website address?

The website address for Aquestive Therapeutics is www.aquestive.com

Which industry sector does Aquestive Therapeutics operate in?

Aquestive Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
NCRANocera Inc	US$ 1.48 (66.20%)	3.55M
MYNAMynaric AG	US$ 0.675 (53.54%)	6.58M
BNOXBionomics Ltd	US$ 0.3674 (45.16%)	5.93M
DRCTDirect Digital Holdings Inc	US$ 7.98 (45.09%)	9.2M
TIVCTivic Health Systems Inc	US$ 0.3227 (43.81%)	6.05M
SLGLSol Gel Technologies Ltd	US$ 1.1599 (-29.70%)	3.14M
FRESFresh2 Group Ltd	US$ 0.67 (-21.18%)	42.94k
ANEBAnebulo Pharmaceuticals Inc	US$ 1.0201 (-18.39%)	2.65k
JZXNJiuzi Holdings Inc	US$ 1.45 (-12.12%)	312
VIVKVivakor Inc	US$ 1.16 (-11.45%)	240
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.4398 (9.10%)	12.96M
DRCTDirect Digital Holdings Inc	US$ 7.98 (45.09%)	9.2M
MYNAMynaric AG	US$ 0.675 (53.54%)	6.58M
TIVCTivic Health Systems Inc	US$ 0.3227 (43.81%)	6.05M
BNOXBionomics Ltd	US$ 0.3674 (45.16%)	5.93M